rhodioloside has been researched along with Diabetes Mellitus, Type 2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Wang, J; Wang, W; Wang, X; Yang, L; Zhou, L | 1 |
Bian, F; Chen, L; Hao, X; Lei, P; Lu, W; Ma, W; Wang, Q; Zhang, L; Zhang, Y; Zhao, Y; Zheng, T | 1 |
Bai, X; Bian, F; Chen, X; Chi, J; Jin, S; Li, W; Wu, D; Wu, G; Xing, S; Yang, X; Zhang, Y; Zheng, T | 1 |
Alameddine, A; Ayer, A; Bourreau, J; Custaud, MA; Derbre, S; Fajloun, Z; Gauguier, D; Gauquelin-Koch, G; Navasiolava, N; Yuan, M | 1 |
Fu, XJ; Hou, S; Li, M; Yang, XH; Zhang, CZ; Zhang, XR; Zhu, DS | 1 |
5 other study(ies) available for rhodioloside and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Cell Line; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hepatitis; HMGB1 Protein; Humans; Hypoglycemic Agents; Liver; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols; Receptor for Advanced Glycation End Products; Signal Transduction; Toll-Like Receptor 4 | 2020 |
Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis.
Topics: AMP-Activated Protein Kinases; Analgesics; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia, Spinal; Glucosides; Hypoglycemic Agents; Inflammasomes; Insulin Resistance; Male; Neuralgia; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pain Threshold; Phenols; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Oxygen Consumption; Pancreas; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2015 |
The cardiovascular effects of salidroside in the Goto-Kakizaki diabetic rat model.
Topics: Animals; Aorta; Blood Pressure; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Endothelium, Vascular; Glucose Intolerance; Glucosides; Guanylate Cyclase; Heart Rate; Hyperglycemia; Hypertension; Male; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Phenols; Rats; Rats, Inbred WKY; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vasodilation | 2015 |
Salidroside-regulated lipid metabolism with down-regulation of miR-370 in type 2 diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Down-Regulation; Glucosides; Insulin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Phenols | 2016 |